Per BBIO, Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Through ...
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
Shares of Amgen (NASDAQ: AMGN) are down by 6% in the last 30 days as I write this -- a larger-than-normal amount for a large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback